Dallah Healthcare Co. reported a net profit of SAR 360.1 million for 2023, growth of 31% from SAR 274.5 million a year earlier
| Item | 2022 | 2023 | Change |
|---|---|---|---|
| Revenues | 2,487.98 | 2,942.90 | 18.3 % |
| Gross Income | 895.10 | 1,078.67 | 20.5 % |
| Operating Income | 392.49 | 471.60 | 20.2 % |
| Net Income | 274.46 | 360.12 | 31.2 % |
| Average Shares | 90.00 | 97.68 | 8.5 % |
| EPS (Riyals) | 3.05 | 3.69 | 20.9 % |
Revenues rose by 18.3% year-on-year (YoY) to SAR 2.94 billion, due to the increase in the number of visitors to the group’s hospitals and higher occupancy rates following improved operations and capacity.
Gross profit led up 21% YoY on higher revenue. Meanwhile, Dallah noted associates’ improved performance and the company’s acquisition of an additional interest in an associated company in 2023.
Dallah recorded Zakat provisions at SAR 18.5 million in 2022, while in 2023 amended Zakat assessments were received in favor of the company.
Q4 2023 net profit rose 45% YoY to SAR 113.7 million.
On a quarterly basis, net profit grew 14.9%, from SAR 98.87 million.
| Item | Q4 2022 | Q4 2023 | Change |
|---|---|---|---|
| Revenues | 693.88 | 806.01 | 16.2 % |
| Gross Income | 239.81 | 295.94 | 23.4 % |
| Operating Income | 101.69 | 134.34 | 32.1 % |
| Net Income | 78.44 | 113.65 | 44.9 % |
| Average Shares | 90.00 | 97.68 | 8.5 % |
| EPS (Riyals) | 0.87 | 1.16 | 33.5 % |
| Item | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Revenues | 749.83 | 806.01 | 7.5 % |
| Gross Income | 280.86 | 295.94 | 5.4 % |
| Operating Income | 124.75 | 134.34 | 7.7 % |
| Net Income | 98.87 | 113.65 | 14.9 % |
| Average Shares | 97.68 | 97.68 | - |
| EPS (Riyals) | 1.01 | 1.16 | 14.9 % |
Total shareholders’ equity, after minority interest, stood at SAR 3.20 billion by Dec. 31, 2023, compared to SAR 1.98 billion a year earlier.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}